Si Tuen Lee-Hoeflich - Genentech Res & Early Dev

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 33 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure 5 from A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich,Lisa Crocker,Evelyn Yao,Thinh Pham,Xander Munroe,Klaus P. Hoeflich,Mark X. Sliwkowski,Howard M. Stern

crossref（2023）

引用0浏览0引用

Modulation of Biomarkers by BET Inhibitor, BMS-986158, Including JAK2 Variant Allele Frequency (VAF), Bone Marrow (BM) Fibrosis, and Reversal of Abnormal Cytokine Production in Intermediate- or High-Risk Myelofibrosis (MF)

Si Tuen Lee-Hoeflich,Christopher Brueckner, Lawrence Litalien, Ke Xu,Sharmila Das, Laura Corella, Sherif Daouti,Oriana Esposito,Emma Lees, Yu Liu,Zariana Nikolova,Christopher Tehlirian,Shodeinde Coker,Bin Wu

Blood（2023）

引用0浏览0引用

Supplementary Figure 2 from A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich,Lisa Crocker,Evelyn Yao,Thinh Pham,Xander Munroe,Klaus P. Hoeflich,Mark X. Sliwkowski,Howard M. Stern

crossref（2023）

引用0浏览0引用

Supplementary Legends 1-6 from A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich,Lisa Crocker,Evelyn Yao,Thinh Pham,Xander Munroe,Klaus P. Hoeflich,Mark X. Sliwkowski,Howard M. Stern

crossref（2023）

引用0浏览0引用

Supplementary Figure 2 from A Central Role for HER3 in ≪i>her2-Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich,Lisa Crocker,Evelyn Yao,Thinh Pham,Xander Munroe,Klaus P. Hoeflich,Mark X. Sliwkowski,Howard M. Stern

openalex（2023）

引用0浏览0引用

Supplementary Figure 1 from A Central Role for HER3 in ≪i>her2-Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich,Lisa Crocker,Evelyn Yao,Thinh Pham,Xander Munroe,Klaus P. Hoeflich,Mark X. Sliwkowski,Howard M. Stern

openalex（2023）

引用0浏览0引用

Figure S5 from Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies

Lawrence L'Italien, Olivia Orozco,Tinya Abrams, Lisa Cantagallo,Anu Connor,Jayesh Desai,Hilmar Ebersbach,Hans Gelderblom,Keith Hoffmaster,Emma Lees,Heiko Maacke,Siew Schleyer,Darko Skegro,Si Tuen Lee-Hoeflich

crossref（2023）

引用0浏览0引用

BMS-986158, a Potent BET Inhibitor, in Combination with Ruxolitinib or Fedratinib in Patients (pts) with Intermediate- or High-Risk Myelofibrosis (MF): Updated Results from a Phase 1/2 Study

David Lavie,Vincent Ribrag,Michael Loschi,Costas K. Yannakou,Maan Alwan, Adi Schacham Abulafia,Jesus Maria Hernandez-Rivas,Yulia Volchek,Chun Yew Fong,Massimiliano Bonifacio,Jean-Jacques Kiladjian,Jean-Christophe Ianotto,Valentin Garcia Gutierrez,Alessandra Tucci,Blanca Xicoy,Haifa Kathrin Al-Ali,Moshe Talpaz,Jonathan M. Gerber,Indu Raman,Ciprian Tomuleasa,Si Tuen Lee-Hoeflich,Sharmila Das,Bin Wu, Qian Zhao, Eunhee Kim,Oriana Esposito, Yu Liu, Zariana Nikolova,Christopher Tehlirian,Shodeinde Coker, Rosa Ayala

Bloodno. Supplement 1 (2023): 623-623

引用0浏览0引用

Supplementary Figure 4 from A Central Role for HER3 in ≪i>her2-Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich,Lisa Crocker,Evelyn Yao,Thinh Pham,Xander Munroe,Klaus P. Hoeflich,Mark X. Sliwkowski,Howard M. Stern

openalex（2023）

引用0浏览0引用

Supplementary Figure 1 from A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich,Lisa Crocker,Evelyn Yao,Thinh Pham,Xander Munroe,Klaus P. Hoeflich,Mark X. Sliwkowski,Howard M. Stern

crossref（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn